The MEVPRO clinical trial program is an investigational prostate cancer treatment option for patients with metastatic prostate cancer. These clinical trials provide patients with the study medicine Mevrometostat, which is taken as tablets twice per day with enzalutamide. How does Mevrometostat work? The study medicine targets the EZH2 protein known for controlling cell growth. In some people, the EZH2 gene may become abnormal or make too much of the proteins, which can cause prostate cancer cells to grow and the cancer to progress. By blocking the abnormal EZH2 activity in cells, the study medicine may help prevent or delay hormone therapy resistance and cancer progression.
This could be an important development and make a difference in outcomes for men with prostate cancer that become resistant to hormone therapy. These clinical trials are meant to help patients diagnosed with metastatic castrate-resistant prostate cancer (mCRPC). mCRPC is an advanced form of prostate cancer that no longer responds to hormone therapy.
Who Can Join the MEVPRO Clinical Trials?
Men aged 18 years or older with metastatic prostate cancer can sign up for the MEVPRO clinical trials. The study will determine whether Mevrometostat can delay or stop the growth of metastatic prostate cancer. Trial participants will receive either standard-of-care treatment alone or in combination with Mevrometostat.
Why Should You Participate?
When you join a clinical trial, you can gain access to innovative treatments as well as contribute toward the greater understanding and advancement of prostate cancer research. Patient safety is essential, and participants can choose to leave the trial at any point without any impact on their standard of care. Your health will also be carefully monitored throughout the trial. If your health worsens, the research team will help you decide on the best course of action including stopping clinical trial participation. Yet, you may also find a delay or end to your prostate cancer progression. Before you participate, you will be given all the details about the clinical trial, including the potential benefits and risks of taking part.
How Can You Get Involved?
Talk to your doctor to see if the MEVPRO clinical trial program is the right choice for you. Visit PHENTrials.com for more detailed descriptions of the clinical trials and a video about the Mevrometostat study medicine. For more information and resources, please reach out to your healthcare provider and contact PHEN.
Find Your Trial!
To find out details about more than 600 prostate cancer clinical trials, visit: PHENTrials.com.
Remember “Knowledge and Participation” Is Your Best Defense Against Prostate Cancer
